Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9698410, 13 pages
https://doi.org/10.1155/2017/9698410
Research Article

Involvement of the PI3K/Akt/NF-κB Signaling Pathway in the Attenuation of Severe Acute Pancreatitis-Associated Acute Lung Injury by Sedum sarmentosum Bunge Extract

1Department of Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
2YueQing Affiliated Hospital of Wenzhou Medical University, YueQing People’s Hospital, Yueqing, Zhejiang Province, China
3Zhejiang Provincial Top Key Discipline in Surgery, Wenzhou Key Laboratory of Surgery, Department of Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
4Wenzhou Medical University, Wenzhou, Zhejiang Province, China
5Shengli Oilfield Central Hospital, Dongying, Shandong Province, China
6Department of Surgery, Clinical Sciences Lund, Lund University and Lund University Hospital, Sweden

Correspondence should be addressed to Mengtao Zhou; nc.ude.umw@oatgnemuohz

Received 21 July 2017; Revised 19 September 2017; Accepted 22 October 2017; Published 5 December 2017

Academic Editor: Fabrizio Montecucco

Copyright © 2017 Yuepeng Jin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. I. Heath, A. Cruickshank, M. Gudgeon, A. Jehanli, A. Shenkin, and C. W. Imrie, “Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis,” Gut, vol. 34, no. 1, pp. 41–45, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Montravers, S. Chollet-Martin, J. P. Marmuse, M. A. Gougerot-Pocidalo, and J. M. Desmonts, “Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 5, pp. 1527–1533, 1995. View at Publisher · View at Google Scholar
  3. A. C. De Beaux, A. S. Goldie, J. A. Ross, D. C. Carter, and K. C. H. Fearon, “Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis,” British Journal of Surgery, vol. 83, no. 3, pp. 349–353, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Bhatia, M. Brady, S. Shokuhi, S. Christmas, J. P. Neoptolemos, and J. Slavin, “Inflammatory mediators in acute pancreatitis,” The Journal of Pathology, vol. 190, no. 2, pp. 117–125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Buter, C. W. Imrie, C. R. Carter, S. Evans, and C. J. McKay, “Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis,” British Journal of Surgery, vol. 89, no. 3, pp. 298–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Bhatia and S. Moochhala, “Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome,” The Journal of Pathology, vol. 202, no. 2, pp. 145–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Zhang, P. Neuhöfer, L. Song et al., “IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 1019–1031, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Surbatovic, K. Jovanovic, S. Radakovic, and N. Filipovic, “Pathophysiological aspects of severe acute pancreatitis-associated lung injury,” Srpski Arhiv za Celokupno Lekarstvo, vol. 133, no. 1-2, pp. 76–81, 2005. View at Publisher · View at Google Scholar
  9. C. W. Imrie, J. C. Ferguson, D. Murphy, and L. H. Blumgart, “Arterial hypoxia in acute pancreatitis,” British Journal of Surgery, vol. 64, no. 3, pp. 185–188, 1977. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Steinberg and S. Tenner, “Acute pancreatitis,” The New England Journal of Medicine, vol. 330, no. 17, pp. 1198–1210, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Gloor, C. A. Müller, M. Worni, M. E. Martignoni, W. Uhl, and M. W. Büchler, “Late mortality in patients with severe acute pancreatitis,” British Journal of Surgery, vol. 88, no. 7, pp. 975–979, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Tenner, G. Sica, M. Hughes et al., “Relationship of necrosis to organ failure in severe acute pancreatitis,” Gastroenterology, vol. 113, no. 3, pp. 899–903, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. Johnson and M. Abu-Hilal, “Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis,” Gut, vol. 53, no. 9, pp. 1340–1344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Lei, W. Minghao, Y. Xiaonan, X. Ping, L. Ziqi, and X. Qing, “Acute lung injury in patients with severe acute pancreatitis,” The Turkish Journal of Gastroenterology, vol. 24, no. 6, pp. 502–507, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Chooklin, “Pathogenic aspects of pulmonary complications in acute pancreatitis patients,” Hepatobiliary & Pancreatic Diseases International, vol. 8, no. 2, pp. 186–192, 2009. View at Google Scholar · View at Scopus
  16. H.-K. Yum, J. Arcaroli, J. Kupfner et al., “Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury,” The Journal of Immunology, vol. 167, no. 11, pp. 6601–6608, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Samuel, S. Zaheer, J. J. Nelson, M. A. Yorek, and A. Zaheer, “CCK-A receptor induction and p38MAPK and NF-κB activation in acute pancreatitis,” Pancreatology, vol. 4, no. 1, pp. 49–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Severgnini, S. Takahashi, L. M. Rozo et al., “Activation of the STAT pathway in acute lung injury,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 286, no. 6, pp. L1282–L1292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S.-H. Kan, F. Huang, J. Tang, Y. Gao, and C.-L. Yu, “Role of intrapulmonary expression of inducible nitric oxide synthase gene and nuclear factor κb activation in severe pancreatitis-associated lung injury,” Inflammation, vol. 33, no. 5, pp. 287–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Luo, Y. Zhu, Z. Zhang, H. Chen, and Y. Wang, “Clinical observation on the combined therapy of sitagliptin with insulin for patients with brittle diabetes,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 40, pp. 1089–1095, 2015. View at Google Scholar
  21. T. De Campos, J. Deree, and R. Coimbra, “From acute pancreatitis to end-organ injury: Mechanisms of acute lung injury,” Surgical Infections, vol. 8, no. 1, pp. 107–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Akbarshahi, A. H. Rosendahl, G. Westergren-Thorsson, and R. Andersson, “Acute lung injury in acute pancreatitis—a waiting the big leap,” Respiratory Medicine, vol. 106, no. 9, pp. 1199–1210, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Chen, J. Wang, and D. Wan, “Determination of total flavonoids in three Sedum crude drugs by UV-Vis spectrophotometry,” Pharmacognosy Magazine, vol. 6, no. 24, pp. 259–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. T. H. Kang, H. O. Pae, J. C. Yoo et al., “Antiproliferative effects of alkaloids from Sedum sarmentosum on murine and human hepatoma cell lines,” Journal of Ethnopharmacology, vol. 70, no. 2, pp. 177–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. W.-L. Jiang, Y. Xu, S.-P. Zhang, H.-B. Zhu, and J. Hou, “Tricin 7-glucoside protects against experimental cerebral ischemia by reduction of NF-κB and HMGB1 expression,” European Journal of Pharmaceutical Sciences, vol. 45, no. 1-2, pp. 50–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Dong, C. Xu, T. Cheng, and S. Zhou, “Complete chloroplast genome of Sedum sarmentosum and chloroplast genome evolution in Saxifragales,” PLoS ONE, vol. 8, no. 10, Article ID e77965, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Morikawa, Y. Zhang, S. Nakamura, H. Matsuda, O. Muraoka, and M. Yoshikawa, “Bioactive constituents from Chinese natural medicines. XXII. Absolute structures of new megastigmane glycosides, sedumosides E1, E 2, E3, F1, F2, and G, from Sedum sarmentosum (Crassulaceae),” Chemical & Pharmaceutical Bulletin, vol. 55, no. 3, pp. 435–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-J. Jung, H.-J. Kang, Y. S. Song, E.-H. Park, Y.-M. Kim, and C.-J. Lim, “Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Sedum sarmentosum extract,” Journal of Ethnopharmacology, vol. 116, no. 1, pp. 138–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Bai, H. Lu, L. Hu, D. Hong, L. Ding, and B. Chen, “Effect of Sedum sarmentosum BUNGE extract on aristolochic acid-induced renal tubular epithelial cell injury,” Journal of Pharmacological Sciences, vol. 124, no. 4, pp. 445–456, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Ninomiya, T. Morikawa, Y. Zhang et al., “Bioactive constituents from Chinese natural medicines. XXIII.1 absolute structures of new megastigmane glycosides, sedumosides A4, A5, A6, H, and I, and hepatoprotective megastigmanes from Sedum sarmentosum,” Chemical & Pharmaceutical Bulletin, vol. 55, no. 8, pp. 1185–1191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M.-M. Wang, T. Zhang, L.-H. Yang et al., “Sedum sarmentosun bunge extraction ameliorated severe acute pancreatitis-induced lung injury: an experimental research,” Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi, vol. 35, no. 2, pp. 228–233, 2015. View at Google Scholar · View at Scopus
  32. H. J. Aho, S. M.-L. Koskensalo, and T. J. Nevalainen, “Experimental pancreatitis in the rat: Sodium taurocholate-induced acute haemorrhagic pancreatitis,” Scandinavian Journal of Gastroenterology, vol. 15, no. 4, pp. 411–416, 1980. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Schmidt, D. W. Rattner, K. Lewandrowski et al., “A better model of acute pancreatitis for evaluating therapy,” Annals of Surgery, vol. 215, no. 1, pp. 44–56, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. M. O. Osman, J. U. Kristensen, N. O. Jacobsen et al., “A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits,” Gut, vol. 43, no. 2, pp. 232–239, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. A. S. Haqqani, J. K. Sandhu, and H. C. Birnboim, “A myeloperoxidase-specific assay based upon bromide-dependent chemiluminescence of luminol,” Analytical Biochemistry, vol. 273, no. 1, pp. 126–132, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. C. J. Shields, D. C. Winter, and H. P. Redmond, “Lung injury in acute pancreatitis: Mechanisms, prevention, and therapy,” Current Opinion in Critical Care, vol. 8, no. 2, pp. 158–163, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Wei, Q. Huang, J. Li et al., “Taurine attenuates liver injury by downregulating phosphorylated p38 MAPK of Kupffer cells in rats with severe acute pancreatitis,” Inflammation, vol. 35, no. 2, pp. 690–701, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-L. Frossard, A. Saluja, L. Bhagat et al., “The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury,” Gastroenterology, vol. 116, no. 3, pp. 694–701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Closa, L. Sabater, L. Fernández-Cruz, N. Prats, E. Gelpí, and J. Roselló-Catafau, “Activation of alveolar macrophages in lung injury associated with experimental acute pancreatitis is mediated by the liver,” Annals of Surgery, vol. 229, no. 2, pp. 230–236, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Chen, S. Xu, W.-X. Wang et al., “Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury,” Archives of Medical Research, vol. 40, no. 2, pp. 79–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-D. Ren, Y.-J. Xing, K.-H. Fan et al., “Pharmacological blockade of the MaxiK channel attenuates experimental acute pancreatitis and associated lung injury in rats,” International Immunopharmacology, vol. 21, no. 1, pp. 220–224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Chen, L. Huang, Y. Zhang, M. Qiao, W. Yao, and Y. Yuan, “The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity,” International Journal of Molecular Medicine, vol. 27, no. 5, pp. 731–738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. D. E. Williard, E. Twait, Z. Yuan, A. B. Carter, and I. Samuel, “Nuclear factor kappa B-dependent gene transcription in cholecystokinin- and tumor necrosis factor-α-stimulated isolated acinar cells is regulated by p38 mitogen-activated protein kinase,” The American Journal of Surgery, vol. 200, no. 2, pp. 283–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Sun, S. Dragon, A. Becker, and A. S. Gounni, “Leptin Inhibits Neutrophil Apoptosis in Children via ERK/NF-κB-Dependent Pathways,” PLoS ONE, vol. 8, no. 1, Article ID e55249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Twait, D. E. Williard, and I. Samuel, “Dominant negative p38 mitogen-activated protein kinase expression inhibits NF-κB activation in AR42J cells,” Pancreatology, vol. 10, no. 2-3, pp. 119–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. K. Manna and B. B. Aggarwal, “Wortmannin inhibits activation of nuclear transcription factors NF-κB and activated protein-1 induced by lipopolysaccharide and phorbol ester,” FEBS Letters, vol. 473, no. 1, pp. 113–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Kim, C. Yang, A. Shin et al., “Mycobacterial heparin-binding hemagglutinin antigen activates inflammatory responses through PI3-K/Akt, NF-κB, and MAPK pathways,” Immune Network, vol. 11, no. 2, pp. 123–133, 2011. View at Publisher · View at Google Scholar
  48. S. A. Reddy, J. H. Huang, and W. S. Liao, “Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation,” The Journal of Immunology, vol. 164, pp. 1355–1363, 2000. View at Google Scholar
  49. Y. Sailai, X. Yu, P. Baiheti, H. Tang, Y. Li, and M. Xu, “Influence of nuclear factor κb activation on inflammatory mediators of alveolar macrophages in rats with acute necrotizing pancreatitis,” Journal of Investigative Medicine, vol. 58, no. 1, pp. 38–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Satoh, T. Shimosegawa, M. Fujita et al., “Inhibition of nuclear factor-κB activation improves the survival of rats with taurocholate pancreatitis,” Gut, vol. 44, no. 2, pp. 253–258, 1999. View at Publisher · View at Google Scholar · View at Scopus